- Home
- WEN vs IMTX Comparison
WEN vs IMTX Comparison
Compare WEN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WEN | IMTX |
|---|---|---|
| Founded | 1969 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | WEN | IMTX |
|---|---|---|
| Price | $6.78 | $10.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 22 | 5 |
| Target Price | $8.88 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 7.2M | 334.7K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $2,176,891,000.00 | N/A |
| Revenue This Year | $2.35 | N/A |
| Revenue Next Year | $0.94 | $25.91 |
| P/E Ratio | $7.99 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.63 | $3.94 |
| 52 Week High | $13.06 | $12.41 |
Technical Indicators
Market Signals| Indicator | WEN | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 62.50 |
| Support Level | $6.73 | $9.61 |
| Resistance Level | $7.34 | $11.30 |
| Average True Range (ATR) | 0.24 | 0.47 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 25.41 | 89.25 |
Price Performance
Historical ComparisonAbout WEN Wendy's Company (The)
The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.